Shalaks Pharmaceuticals Pvt Ltd, a under liquidation private limited company, was established on 30 November 1977 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74899DL1977PTC008799. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.42 M.
It upholds a compliant status. Its leadership includes Rajiv Dhingra (Director), Pavan Kaul (Director), Roop Narain Gupta (Director). Past directors included Rajiv Dhingra, Pavan Kaul, Vinod Kumar Nangia. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C3 Puja Housekaram Pura Commercial Center Milan Complex, New Delhi, Delhi, 110015.
U74899DL1977PTC008799
008799
30 November 1977
₹2.00 M
₹0.42 M
Roc Delhi
Unlisted
Under Liquidation
Explore comprehensive insights into Shalaks Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Dhingra | Director | 04 Jan 2018 | Current |
| Pavan Kaul | Director | 04 Jan 2018 | Current |
| Roop Narain Gupta | Director | 01 Nov 1981 | Current |
| Ashu Gupta | Irp/Rp/Liquidator | 11 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2011 | Past |
| Pramod Abcsdd | Director | 15 Oct 2013 | Past |
| Pramod Abcsdd | Managing Director | 04 Jan 2018 | Past |
| Pramod Abcsdd | Director | 04 Jan 2018 | Past |
| Pramod Abcsdd | Managing Director | 04 Jan 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shalaks Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.21% decrease. The company also saw a slight improvement in profitability, with a 8.13% increase in profit. The company's net worth moved up by a moderate rise of 1.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Shalaks Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Shalaks Pharmaceuticals has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shalaks Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shalaks Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ashu Gupta was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 11 Feb 2025 & has been associated with this company since 11 months 6 days . was documented.
Shalaks Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Shalaks Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Rajiv Dhingra was appointed as a Director was appointed as a Director on 04 Jan 2018 & has been associated with this company since 8 years 13 days . was recorded as a recent event.
The activity Pavan Kaul was appointed as a Director was appointed as a Director on 04 Jan 2018 & has been associated with this company since 8 years 13 days . was completed.
The activity Roop Narain Gupta was appointed as a Director was appointed as a Director on 01 Nov 1981 & has been associated with this company since 44 years 2 months . was completed.
The CIN of Shalaks Pharmaceuticals Pvt Ltd is U74899DL1977PTC008799.
Shalaks Pharmaceuticals Pvt Ltd is headquartered at C3 Puja Housekaram Pura Commercial Center Milan Complex, New Delhi, Delhi, 110015.
Shalaks Pharmaceuticals Pvt Ltd was incorporated on 30 November 1977.
The current directors of Shalaks Pharmaceuticals Pvt Ltd are
The primary industry of Shalaks Pharmaceuticals Pvt Ltd is Pharma.
Shalaks Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Shalaks Pharmaceuticals Pvt Ltd is ₹2.00 M, and the paid-up capital is ₹0.42 M.
The compliance status of Shalaks Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX